Daichi Miyaoka

Effects of denosumab as compared with parathyroidectomy regarding calcium, renal, and bone involvement in osteoporotic patients with primary hyperparathyroidism

M. Kurajoh, M. Emoto, M. Inaba, 2020, Endocrine.

Effects of burosumab on osteocalcin and bone mineral density in patient with 15-year history of nonremission tumor-induced osteomalacia initially treated with conventional therapy: Case report

M. Kurajoh, M. Emoto, S. Yamada, 2020, Bone reports.

Denosumab Improves Glomerular Filtration Rate in Osteoporotic Patients With Normal Kidney Function by Lowering Serum Phosphorus

M. Kurajoh, M. Emoto, M. Inaba, 2019, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Impaired residual renal function predicts denosumab-induced serum calcium decrement as well as increment of bone mineral density in non-severe renal insufficiency

M. Emoto, M. Inaba, S. Yamada, 2018, Osteoporosis International.

Effects of Teriparatide and Sequential Minodronate on Lumbar Spine Bone Mineral Density and Microarchitecture in Osteoporosis

M. Emoto, M. Inaba, S. Yamada, 2017, Calcified Tissue International.

Characterization of the human gut virome in metabolic and autoimmune diseases

S. Uematsu, K. Fujimoto, D. Miyaoka, 2022, Inflammation and Regeneration.

Attenuated Dentin Matrix Protein 1 Enhances Fibroblast Growth Factor 23 in Calvaria in a Primary Hyperparathyroidism Model.

M. Kurajoh, M. Emoto, M. Inaba, 2019, Endocrinology.

increased bone mineral density and improved metabolic bone markers in patients with hypophosphatemic rickets osteomalacia treated with the calcimimetic cinacalcet

M. Emoto, M. Inaba, Y. Imanishi, 2018 .

Effect of etelcalcetide on parathyroid hormone secretion by primary hyperparathyroidism patient-derived primary parathyroid cells

M. Emoto, M. Inaba, Y. Imanishi, 2020, Journal of Bone and Mineral Metabolism.

Parathyroid Hormone Regulates Circulating Levels of Sclerostin and FGF23 in a Primary Hyperparathyroidism Model

A. Arnold, M. Kurajoh, M. Emoto, 2022, Journal of the Endocrine Society.

Etelcalcetide decreases the PTH–calcium setpoint without changing maximum and minimum PTH secretion in mice with primary hyperparathyroidism

M. Emoto, M. Inaba, Y. Imanishi, 2020, Journal of Bone and Mineral Metabolism.